China Regenerative Medicine International Limited (08158.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 3Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

3.9x

Market Cap

HKD 54.78M

MomentumView details →

1D Return

+0.00%

YTD Return

−57.14%

RSI (14)

27.7

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

3.9x

Market Cap

HKD 54.78M

RSI (14)

27.7

MomentumView details →

1D Return

+0.00%

YTD Return

−57.14%

ProfitabilityView details →

Gross Margin

56.41%

Net Margin

27.83%

EBITDA Margin

22.05%

ROE (TTM)

52.59%

ROA (TTM)

20.84%

Asset Turnover

0.75x

GrowthView details →

Revenue YoY

+84.23%

EPS YoY

+439.56%

FCF YoY

+560.47%

Revenue CAGR 3Y

+20.16%

EPS CAGR 3Y

+78.17%

EBITDA YoY

+277.70%

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.67x

Current Ratio

1.57x

Quick Ratio

1.35x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

107.27M

Net Income (TTM)

29.85M

Op. CF (TTM)

15.62M

Latest newsMore news →

No recent news for 08158.HK.

Similar companies

ImageneBio IncIMA Immutep LimitedIMMP Kezar Life Sciences, Inc.KZR Seres Therapeutics, Inc.MCRB Coeptis Therapeutics, Inc.COEP Instil Bio, Inc.TIL Find similar companies →

Latest newsMore news →

No recent news for 08158.HK.